Latest news
Sandoz Group AG 2026 Q2 - Results - Earnings Call Presentation (OTCMKTS:SDZNY) 2026-08-08 - Seeking AlphaSeeking Alpha · Sat, 08 Aug 2026 23:22:39 GMTGeneric drug manufacturer Sandoz agrees to $400 million settlement over allegations of scheme to inflate prescription prices, limit competition - nottinghammd.comnottinghammd.com · Fri, 07 Aug 2026 10:30:00 GMTSandoz takes further steps to resolve legacy U.S. generic medicine litigation - Drug Store NewsDrug Store News · Thu, 06 Aug 2026 13:37:43 GMTSandoz Earns ‘Blue Chip’ Status With Biosimilars Growth And GLP-1 Opportunity - insights.citeline.cominsights.citeline.com · Thu, 06 Aug 2026 10:30:54 GMTSandoz Inc. agrees to $469M settlement in generic drug price-fixing case, Tong says - Norwalk HourNorwalk Hour · Thu, 06 Aug 2026 09:07:38 GMTBarclays Maintains SANDOZ GROUP AG(SDZXF.US) With Buy Rating, Cuts Target Price to $99.69 - MoomooMoomoo · Thu, 06 Aug 2026 07:31:00 GMTGoldman Sachs Initiates SANDOZ GROUP AG(SDZXF.US) With Buy Rating, Announces Target Price $96.75 - MoomooMoomoo · Thu, 06 Aug 2026 05:31:00 GMTSANDOZ AGREES TO $400 MILLION SETTLEMENT OVER GENERIC DRUG PRICE-FIXING ALLEGATIONS - 3B Media News3B Media News · Wed, 05 Aug 2026 21:06:40 GMT